Recent Quotes (30 days)

You have no recent quotes
chg | %

MedReleaf Corp  

(Public, TSE:LEAF)   Watch this stock  
Find more results for LEAF
-0.11 (-0.54%)
Delayed:   10:11a.m. EST
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 20.18 - 20.90
52 week 6.81 - 31.25
Open 20.70
Vol / Avg. 56,016.00/912,819.00
Mkt cap 2.03B
P/E 830.67
Div/yield     -
EPS 0.02
Shares 99.80M
Beta     -
Inst. own     -
Jan. 9, 2018
MedReleaf Corp at ICR Conference

Key stats and ratios

Q3 (Sep. '17) 2017
Net profit margin -21.65% 27.16%
Operating margin 0.39% 38.89%
EBITD margin - -34.39%
Return on average assets -5.47% 23.09%
Return on average equity -6.38% 33.24%
Employees 135 -
CDP Score - -


Markham Industrial Park

Website links


MedReleaf Corp is a Canada-based company which operates as a licensed producer of cannabis-based pharmaceutical products. The Company produces and sells its dried cannabis and cannabis oil products, including cannabis oil capsules. The Company produce an aggregate of up to 6,000 kilograms of dried cannabis and up to 1,760 kilograms of cannabis oil, and to sell and distribute within Canada an aggregate of up to 5,000 kilograms of dried cannabis, up to 1,319 kilograms of bottled cannabis oil, and up to 440 kilograms of encapsulated cannabis oil. The Company is an analytically-driven organization focused on patient care, scientific innovation, and advancing the understanding of the therapeutic benefits of cannabis.

Officers and directors

Eitan Popper President
Age: 35
Neil Closner Chief Executive Officer, Executive Director
Igor Gimelshtein Chief Financial Officer, Corporate Secretary
Angelo Fefekos Vice President - Clinical Affairs and Quality Compliance
Darren Karasiuk Vice President - Strategy
Ivan Latysh Vice President - Information Technology
Lloyd M. Segal Non-Executive Chairman of the Board
Age: 51
Norma Beauchamp Non-Executive Director
Ronald Funk Non-Executive Director
Deborah E. Rosati Non-Executive Director
Age: 55